168 related articles for article (PubMed ID: 33831942)
21. Targeting the SHIP1 Pathway Fails to Show Treatment Benefit in Interstitial Cystitis/Bladder Pain Syndrome: Lessons Learned from Evaluating Potentially Effective Therapies in This Enigmatic Syndrome.
Nickel JC; Moldwin R; Hanno P; Dmochowski R; Peters KM; Payne C; Wein A
J Urol; 2019 Aug; 202(2):301-308. PubMed ID: 31090511
[TBL] [Abstract][Full Text] [Related]
22. A prospective randomized controlled multicentre trial comparing intravesical DMSO and chondroïtin sulphate 2% for painful bladder syndrome/interstitial cystitis.
Tutolo M; Ammirati E; Castagna G; Klockaerts K; Plancke H; Ost D; Van der Aa F; De Ridder D
Int Braz J Urol; 2017; 43(1):134-141. PubMed ID: 28124536
[TBL] [Abstract][Full Text] [Related]
23. Second multicenter, randomized, double-blind, parallel-group evaluation of effectiveness and safety of intravesical sodium chondroitin sulfate compared with inactive vehicle control in subjects with interstitial cystitis/bladder pain syndrome.
Nickel JC; Hanno P; Kumar K; Thomas H
Urology; 2012 Jun; 79(6):1220-4. PubMed ID: 22516357
[TBL] [Abstract][Full Text] [Related]
24. Systematic Review and Meta-Analysis of Intravesical Hyaluronic Acid and Hyaluronic Acid/Chondroitin Sulfate Instillation for Interstitial Cystitis/Painful Bladder Syndrome.
Pyo JS; Cho WJ
Cell Physiol Biochem; 2016; 39(4):1618-25. PubMed ID: 27627755
[TBL] [Abstract][Full Text] [Related]
25. [Intravesical therapy of heparin and lidocaine for interstitial cystitis : a case report].
Matsuo T; Shida Y; Hayashida Y; Sakai H
Hinyokika Kiyo; 2011 Sep; 57(9):513-6. PubMed ID: 22075614
[TBL] [Abstract][Full Text] [Related]
26. Long-term outcomes of intravesical dimethyl sulfoxide/heparin/hydrocortisone therapy for interstitial cystitis/bladder pain syndrome.
Lim YN; Dwyer P; Murray C; Karmakar D; Rosamilia A; Thomas E
Int Urogynecol J; 2017 Jul; 28(7):1085-1089. PubMed ID: 27987022
[TBL] [Abstract][Full Text] [Related]
27. The role of bladder instillation in the treatment of bladder pain syndrome: Is intravesical treatment an effective option for patients with bladder pain as well as LUTS?
Digesu GA; Tailor V; Bhide AA; Khullar V
Int Urogynecol J; 2020 Jul; 31(7):1387-1392. PubMed ID: 32358624
[TBL] [Abstract][Full Text] [Related]
28. Intravesical resiniferatoxin for the treatment of interstitial cystitis: a randomized, double-blind, placebo controlled trial.
Payne CK; Mosbaugh PG; Forrest JB; Evans RJ; Whitmore KE; Antoci JP; Perez-Marrero R; Jacoby K; Diokno AC; O'Reilly KJ; Griebling TL; Vasavada SP; Yu AS; Frumkin LR;
J Urol; 2005 May; 173(5):1590-4. PubMed ID: 15821499
[TBL] [Abstract][Full Text] [Related]
29. The O'Leary-Sant Interstitial Cystitis Symptom Index is a clinically useful indicator of treatment outcome in patients with interstitial cystitis/bladder pain syndrome with Hunner lesions: A post hoc analysis of the Japanese phase III trial of KRP-116D, 50% dimethyl sulfoxide solution.
Yoshimura N; Uno T; Sasaki M; Ohinata A; Nawata S; Ueda T
Int J Urol; 2022 Apr; 29(4):289-296. PubMed ID: 34929761
[TBL] [Abstract][Full Text] [Related]
30. Urinary and psychological outcomes in women with interstitial cystitis/bladder pain syndrome following hyaluronic acid treatment.
Liang CC; Lin YH; Hsieh WC; Huang L
Taiwan J Obstet Gynecol; 2018 Jun; 57(3):360-363. PubMed ID: 29880165
[TBL] [Abstract][Full Text] [Related]
31. Examination of the significant placebo effect in the treatment of interstitial cystitis/bladder pain syndrome.
Bosch PC
Urology; 2014 Aug; 84(2):321-6. PubMed ID: 24958479
[TBL] [Abstract][Full Text] [Related]
32. Intravesical hyaluronic acid and alkalinized lidocaine for the treatment of severe painful bladder syndrome/interstitial cystitis.
Lv YS; Zhou HL; Mao HP; Gao R; Wang YD; Xue XY
Int Urogynecol J; 2012 Dec; 23(12):1715-20. PubMed ID: 22576327
[TBL] [Abstract][Full Text] [Related]
33. Intravesical tacrolimus in treatment of intractable interstitial cystitis/bladder pain syndrome - A pilot study.
Mishra NN; Riedl C; Shah S; Pathak N
Int J Urol; 2019 Jun; 26 Suppl 1():68-72. PubMed ID: 31144739
[TBL] [Abstract][Full Text] [Related]
34. Tanezumab Reduces Pain in Women with Interstitial Cystitis/Bladder Pain Syndrome and Patients with Nonurological Associated Somatic Syndromes.
Nickel JC; Mills IW; Crook TJ; Jorga A; Smith MD; Atkinson G; Krieger JN
J Urol; 2016 Apr; 195(4 Pt 1):942-8. PubMed ID: 26576710
[TBL] [Abstract][Full Text] [Related]
35. Intravesical liposome versus oral pentosan polysulfate for interstitial cystitis/painful bladder syndrome.
Chuang YC; Lee WC; Lee WC; Chiang PH
J Urol; 2009 Oct; 182(4):1393-400. PubMed ID: 19683290
[TBL] [Abstract][Full Text] [Related]
36. A multicentre, prospective, randomised, double-blind study to measure the treatment effectiveness of abobotulinum A (AboBTXA) among women with refractory interstitial cystitis/bladder pain syndrome.
Manning J; Dwyer P; Rosamilia A; Colyvas K; Murray C; Fitzgerald E
Int Urogynecol J; 2014 May; 25(5):593-9. PubMed ID: 24276074
[TBL] [Abstract][Full Text] [Related]
37. The effect of intravesical hyaluronic acid therapy on urodynamic and clinical outcomes among women with interstitial cystitis/bladder pain syndrome.
Peng YC; Yueh-Hsia Chiu S; Feng M; Liang CC
Taiwan J Obstet Gynecol; 2020 Nov; 59(6):922-926. PubMed ID: 33218413
[TBL] [Abstract][Full Text] [Related]
38. Comparative effectiveness and safety of intravesical instillation treatment of interstitial cystitis/bladder pain syndrome: a systematic review and network meta-analysis of randomized controlled trials.
Liu S; Zhang C; Peng L; Lu Y; Luo D
Int Urogynecol J; 2021 May; 32(5):1061-1071. PubMed ID: 32886173
[TBL] [Abstract][Full Text] [Related]
39. A Randomized, Double-blind, Placebo-controlled Trial of Certolizumab Pegol in Women with Refractory Interstitial Cystitis/Bladder Pain Syndrome.
Bosch PC
Eur Urol; 2018 Nov; 74(5):623-630. PubMed ID: 30072210
[TBL] [Abstract][Full Text] [Related]
40. Open Label, Pilot Evaluation of the Safety and Efficacy of Intravesical Sustained Release System of Lidocaine and Oxybutynin (TRG-100) for Patients With Interstitial Cystitis/Bladder Pain Syndrome, Overactive Bladder and Patients With Retained Ureteral Stents Following Endourological Interventions.
Raisin G; Dothan D; Perez D; Ala-Adin N; Kafka I; Shenfeld O; Hatumi S; Malchi N; Gordon A; Touitou D; Moldwin R; Nassar T; Chertin B
Urology; 2023 Aug; 178():42-47. PubMed ID: 37268171
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
